Indian authorities have revoked a patent on a breast cancer drug made by GSK that would have delayed the arrival of generic versions into the country Source
This site uses Cookies to dispense or record information with regards to your visit. By continuing to use this site you agree to the terms outlined in ourCookies used here:Privacy / Disclaimer,